Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Prospective, randomized, double-blind study assessing the effects of levetiracetam compared to placebo in the prevention of early epileptic seizures and late epilepsy in patients with severe traumatic brain injury.

Next Previous
Trial Profile

Prospective, randomized, double-blind study assessing the effects of levetiracetam compared to placebo in the prevention of early epileptic seizures and late epilepsy in patients with severe traumatic brain injury.

Status: Discontinued
Phase of Trial: Phase III

Latest Information Update: 30 Oct 2014

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Levetiracetam (Primary)
  • Indications Epilepsy
  • Focus Therapeutic Use
  • Acronyms TRACK

Most Recent Events

  • 01 Mar 2012 Actual patient number is 23 according to ClinicalTrials.gov.
  • 05 Aug 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
  • 11 Dec 2007 New trial record.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top